Morepen Laboratories Ltd Quarterly Results

Gross Sales

411.58

425.24

465.85

452.78

437.73

Excise Duty

0

0

0

0

0

Net Sales

411.58

425.24

465.85

452.78

437.73

Other Operating Income

0

0

0

0

0

Other Income

30.46

4.41

4.61

5.34

4.99

Total Income

442.04

429.65

470.46

458.12

442.71

Total Expenditure

380.88

401.07

423.61

416.64

393.66

PBIDT

61.16

28.58

46.85

41.48

49.06

Interest

4.18

4.04

4.67

1.34

1.18

PBDT

56.98

24.54

42.18

40.14

47.88

Depreciation

11.28

9.03

16.47

4.93

1.86

Minority Interest Before NP

0

0

0

0

0

Tax

4.65

4.11

0.68

8.52

11.17

Deferred Tax

0

0

4.73

0

0

Reported Profit After Tax

41.04

11.41

20.31

26.69

34.85

Minority Interest After NP

0.17

0.66

-0.01

0

0

Net Profit after Minority Interest

40.87

10.75

20.32

26.69

34.85

Extra-ordinary Items

23.2

0

0

0

0

Adjusted Profit After Extra-ordinary item

17.67

10.75

20.32

26.69

34.85

EPS (Unit Curr.)

0.75

0.2

0.35

0.49

0.65

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

109.58

109.58

109.58

109.58

109.58

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

14.85

6.72

10.05

9.16

11.2

PBDTM(%)

13.84

5.77

9.05

8.86

10.93

PATM(%)

9.97

2.68

4.35

5.89

7.96